Robinson, who served as director of medical affairs and education for 40 Days for Life, has died of heart failure. He was a leading advocate who dedicated the latter half of his life to protecting the unborn and supporting families facing difficult pregnancies.

Robinson died over the weekend, according to an announcement from his wife, Daphne Robinson, and confirmation from Shawn Carney, president of 40 Days for Life.

Click here to sign up for pro-life news alerts from LifeNews.com

“Our dear friend, former abortion doctor, and 40 Days for Life director of medical affairs & education Dr. Haywood Robinson died of heart failure this past weekend,” Carney said. “While our hearts are heavy and filled with sorrow, they are also filled with joy. Haywood’s conversion is a testament to God’s mercy…and one that brings hope to pro-lifers standing up against the greatest evil in history.”

In a public statement, Daphne Robinson wrote: “It is with profound heartache that I personally, publicly, and officially announce the death of my husband, Dr. Haywood Robinson, MD. My Beloved was much beloved, admired and a friend to many. Protecting and advocating for the unborn and defending all vulnerable life created in the image of God was core to who my husband was.”

Robinson began his medical career doing abortions. During his family medicine residency in Southern California in the late 1970s, he learned the dilation and curettage procedure and, together with his first wife, Dr. Noreen Johnson, an OB-GYN, moonlighted at abortion facilities. They later moved to Texas, where they stopped doing abortions, but continued to refer women for abortions.

In March 1986, Robinson experienced a life-changing Christian conversion at a concert. He later described how God opened his eyes to the reality of abortion.

“One of the first things that the Lord did for us was to make us aware of our past and abortion,” he said. “Because what He wanted to do was to take us from darkness to light, from abortion providers to warriors in the pro-life movement.”

He and Johnson became outspoken pro-life advocates. They co-authored the book “The Scalpel and the Soul: Our Radical Transformation as Husband and Wife Abortion Doctors,” published after Johnson’s death in August 2021.

Robinson retired from clinical practice in 2019 and joined 40 Days for Life full-time as its director of medical affairs and education, a role he held for the past seven years. He traveled the country and the world, sharing his testimony, leading prayer vigils outside abortion facilities, and educating others on the medical and moral case for life.

In recent years he also served as director of continuum of care for Journey of a Lifetime, an organization founded by his wife Daphne that offers trauma-informed perinatal support to parents and families who receive a life-limiting or adverse diagnosis during pregnancy or in the NICU.

From the pro-life perspective, Robinson’s life stands as a powerful witness to redemption. Once a participant in the destruction of unborn children, he became a tireless defender of those same children, demonstrating that no past is beyond the reach of grace and that every human life, from conception, bears the image of God.

A Celebration of Life will be held Wednesday, Aug. 5, at Christ Church in College Station, Texas. In lieu of flowers, the family requests donations to Journey of a Lifetime.

The post Abortionist Who Powerfully Converted to Christ and Became a Pro-Life Leader Passes Away appeared first on LifeNews.com.

The Center for Reproductive Rights quickly declared the ruling a “win for science.” It claimed that mifepristone is “exceedingly safe” and that the remaining safeguards exist for political reasons.

That is not what the court decided.

Judge Ballou did not declare mifepristone risk-free. He did not order the FDA to remove every restriction. His ruling found that the agency had not adequately explained why it retained certain requirements in 2023, including certification for prescribers and pharmacies and a patient agreement form. He sent the matter back to the FDA for further consideration.

Click here to sign up for pro-life news alerts from LifeNews.com

In plain English, the court told the FDA to explain itself more fully. That is far different from proving that the restrictions lack a medical purpose.

The decision arose under the Administrative Procedure Act, which requires federal agencies to support their decisions with clear reasoning. Courts can order agencies to reconsider decisions that lack adequate explanation, but they do not settle scientific disputes simply by doing so.

This ruling also represents only one decision in a much larger legal battle. Other federal courts have upheld the FDA’s current mifepristone rules. In 2024, the Supreme Court dismissed a separate challenge because the plaintiffs lacked standing. The Court did not decide whether the FDA acted lawfully or whether its scientific conclusions were correct.

Calling the Virginia ruling a final scientific judgment is advocacy dressed up as analysis.

The claim that mifepristone is “exceedingly safe” also deserves scrutiny. A 2023 population-based study of women in Ontario, published in the Annals of Internal Medicine, found that 10.3 percent of women who underwent chemical abortions visited an emergency department afterward.

The FDA’s own post-marketing reports have documented deaths associated with mifepristone use, including cases involving sepsis and complications from ectopic pregnancies. Determining causation can prove difficult, but that does not make the reports irrelevant.

Other analyses have identified serious complications such as hemorrhage, infection, incomplete abortion, and the need for emergency surgery. The full extent of these problems remains difficult to measure because the FDA no longer requires abortion providers to report most nonfatal complications.

Incomplete abortions are particularly concerning. Some women require additional medication or surgery after the regimen fails to remove all pregnancy tissue. Mail-order distribution and telemedicine can make it harder to confirm gestational age, diagnose ectopic pregnancy, or ensure that women receive timely follow-up care.

The FDA’s statement that mifepristone is “safe and effective” under approved conditions does not prove that every safeguard is unnecessary. Federal regulators routinely impose special controls on drugs with known serious risks. A drug can meet the FDA’s approval standard while still requiring careful prescribing, monitoring, and reporting.

There is also a deeper truth that abortion advocates refuse to acknowledge. Mifepristone works by blocking progesterone, the hormone that sustains pregnancy. Misoprostol then causes contractions to expel the developing child.

The regimen does not merely carry a risk of ending a human life. Ending that life is its intended purpose.

No discussion of “safety” can honestly ignore the unborn child. A successful chemical abortion always ends in death for that child. The Center for Reproductive Rights focuses exclusively on maternal complication statistics because recognizing the second human being would expose the moral emptiness of its argument.

Nor can abortion advocates divide this debate neatly between “science” and “politics.” Decisions about abortion drugs involve medicine, law, federal authority, maternal health, and the government’s responsibility to protect human life. Those questions have surrounded mifepristone since the FDA first approved it in 2000 and continued as the agency expanded its use and removed safeguards.

The Virginia decision is a procedural setback for the Trump administration, not a scientific or moral settlement. Judge Ballou ordered the agency to provide better explanations. He did not prove that mifepristone is harmless, that existing safeguards lack value, or that opposition to chemical abortion rests on politics rather than evidence.

The victory statements cannot conceal the truth. Mifepristone presents real dangers to women, and every successful use deliberately ends the life of an unborn child. Any honest examination of the drug must begin there.

LifeNews.com Note: Raimundo Rojas is the Outreach Director for the National Right to Life Committee. He is a former president of Florida Right to Life and has presented the pro-life message to millions in Spanish-language media outlets. He represents NRLC at the United Nations as an NGO. Rojas was born in Santiago de las Vegas, Havana, Cuba and he and his family escaped to the United States in 1968.

The post No a Judge Did Not Rule Abortion Pills are Safe appeared first on LifeNews.com.

Nakeeya L. Arbogast was charged Monday by the King County Prosecuting Attorney’s Office in connection with the July 11 death of her son. Prosecutors allege she placed the toddler face down in the bathtub, turned on the water and left him unattended while she tended to her two other young children and spoke by phone with the children’s father — despite a domestic violence no-contact order.

The child, who had Down syndrome and significant physical and developmental delays that left him unable to crawl, walk or sit independently without support, was found unconscious on July 9 in the family’s Northgate apartment. Arbogast called 911 and performed chest compressions as directed by the dispatcher. The boy was transported to Seattle Children’s Hospital, where he died two days later from hypoxic brain injury caused by prolonged lack of oxygen.

Click here to sign up for pro-life news alerts from LifeNews.com

Court documents state Arbogast initially estimated she had been away from the bathroom for only a few minutes. Investigators determined it took more than 14 minutes for the bathtub to fill to the level at which the child was later found, indicating he had been left alone longer than she claimed. She acknowledged knowing it was unsafe to leave her son unattended in the tub and said she had previously used a special bathing chair but had left it behind at a former residence because it became moldy and uncomfortable for him.

Prosecutors note the child was particularly vulnerable because of his disabilities and that the offense occurred within sight or sound of another minor child — factors that could serve as aggravating circumstances. Family members had previously heard Arbogast threaten to kill her children, according to charging papers, though she denied any intent to harm her son or ever making such threats.

Arbogast has no prior criminal history in King County. Prosecutors are seeking to maintain her $1 million bail and requesting electronic monitoring, no contact with minors, and other restrictions.

The death of this little boy underscores the profound moral duty to protect the most vulnerable among us. Children with Down syndrome are fully human persons endowed with inherent dignity, yet they face disproportionate risks of devaluation — both in the womb, where the vast majority of prenatally diagnosed cases end in abortion, and after birth, when neglect or indifference can prove fatal. This case is a heartbreaking reminder that every child, regardless of ability, deserves vigilant care and the full protection of society.

The post Woman Faces Manslaughter Charges After Toddler With Down Syndrome Drowns in Bathtub appeared first on LifeNews.com.

Just last week, Senator Britt questioned Acting Attorney General (AG) Todd Blanche at his nomination hearing, highlighting the dangerous lack of an in-person dispensing requirement for mifepristone and asking him to commit to taking action as AG.

“The rise of mail-order chemical abortion drugs endangers not only the lives of unborn babies, but also the health and safety of their mothers. Not to mention the horrifying stories we have heard from women who have been subject to coercion and deception by abusers,” said Senator Britt. “My colleagues and I will continue to fight every day to protect women and children from this dangerous drug by ensuring the rule of law is upheld.”

Click here to sign up for pro-life news alerts from LifeNews.com

In October 2025, Attorney General Murrill filed a lawsuit on behalf of the State of Louisiana and Rosalie Markezich, a victim of Democrats’ harmful decision to remove the in-person dispensing requirement for dangerous chemical abortion drugs. Because of President Biden’s policy, Rosalie’s boyfriend was able to order chemical abortion pills online from an abortionist in California and coerced her to take the drug to kill her unborn child.

“In-person dispensing requirements for chemical abortion drugs saves babies and protects women from coercion,” said Senator Cassidy. “As a strong pro-life doctor, I will always defend the health and safety of mothers and unborn life. These commonsense safeguards must be reinstated immediately.”

The Republican lawmakers argue that the Biden Administration violated federal law by removing the in-person dispensing requirement, and that these protections should be reinstated. Additionally, the amicus brief supports Attorney General Murrill’s motion for preliminary relief, asking for a preliminary injunction ordering the Food and Drug Administration (FDA) to suspend or withdraw the 2023 Risk Evaluation and Mitigation Strategy (REMS) while the case proceeds.

The brief is also supported by Senators Jim Banks (R-Ind.), Marsha Blackburn (R-Tenn.), Ted Budd (R-N.C.), John Cornyn (R-Texas), Kevin Cramer (R-N.D.), Mike Crapo (R-Idaho), Ted Cruz (R-Texas), Steve Daines (R-Mont.), Josh Hawley (R-Mo.), John Hoeven (R-N.D.), Cindy Hyde-Smith (R-Miss.), James Lankford (R-Okla.), Roger Marshall, M.D. (R-Kan.), Rand Paul, M.D. (R-Ky.), Pete Ricketts (R-Neb.), Jim Risch (R-Idaho), Rick Scott (R-Fla.), Tim Sheehy (R-Mont.), and Tommy Tuberville (R-Ala.).

You can read the full amicus brief here.

Senator Britt is a strong champion for pro-life policies, previously joining her colleagues in urging the FDA to review the decision to approve a generic version of mifepristone. She recently joined Senator Marsha Blackburn (R-Tenn.) in introducing the Title X Abortion Provider Prohibition Act to ban federal Title X family-planning grants from going to any entity, such as Planned Parenthood, that performs abortions or funds abortion providers. She also joined Senator James Lankford (R-Okla.) in introducing the Born-Alive Abortion Survivors Protection Act to protect newborns who survive abortion attempts by requiring they receive care from health care practitioners. The Senator has an A+ grade from the Susan B. Anthony Pro-Life America scorecard for her work in protecting the lives of the most vulnerable.

The post Republican Senators Fight to Stop Abortion Pills appeared first on LifeNews.com.

Vaughn, a devoted Christian father of 11 and pro-life advocate, was among a wave of Americans singled out and prosecuted under the Freedom of Access to Clinic Entrances (FACE) Act by the Biden Department of Justice because of their pro-life views. Armed FBI agents descended on his home in the early morning hours, terrifying his family—including his children—in a show of force that was grossly disproportionate to his alleged crime.

Vaughn was eventually convicted of a misdemeanor FACE violation as well as a felony Conspiracy Against Rights violation, even though his only involvement in the event consisted in serving as a messenger between the police and the peaceful protestors. On January 23, 2025, Vaughn and 23 other pro-life advocates were pardoned by President Trump while his case was on appeal.

Click here to sign up for pro-life news alerts from LifeNews.com

With this settlement, the federal government has now affirmed the Biden DOJ’s and FBI’s actions were an abuse of government power.

The settlement brings long-overdue justice to Vaughn and his family and comes in the wake of the Trump administration’s courageous decision to reverse course on politically motivated prosecutions targeting people of faith and instituting new DOJ policy guidance making clear that peaceful pro-life prayer and protest activity are protected by the First Amendment and will no longer be treated as federal crimes.

“This family did nothing wrong. Paul prayed and sang. He bore witness to his faith and for that, the full weight of the federal government was brought crashing down on his front door before the sun rose,” said Steve Crampton, Senior Counsel at Thomas More Society. “What was done to Paul and his family was a profound injustice, and we are grateful that this settlement acknowledges that. We also commend the Trump Department of Justice for having the courage to look at what its predecessor did, call it what it was—an abuse of power—and change course. No American should ever again have to fear an FBI raid for praying and offering hope to women in need.”

Vaughn expressed relief, gratitude, and a determination that his family’s ordeal is not suffered by others.

“My family has been through a traumatic ordeal that never should have happened. But today brings an end to this portion of the story,” said Paul Vaughn. “I am grateful to the members of this Department of Justice who were willing to look honestly at what the prior administration did to our family and so many others and attempt to make it right. I am grateful to President Trump for the pardon that restored my good name, Thomas More Society for their tireless defense, and the countless people who stood with us in prayer. This chapter is finally closed, and our family looks forward with gratitude and hope, as we continue to serve God, advocating for the most vulnerable among us without fear.” Thomas More Society has represented dozens of pro-life clients targeted under the FACE Act in recent years, arguing consistently that the Biden DOJ selectively and aggressively pursued people of faith engaging in constitutionally protected activity.

“This settlement is not just about one family,” added Crampton. “It is a warning and a precedent. The weaponization of federal law enforcement against pro-lifers, against people of faith, against those who dare to stand for the unborn—that era is over. At Thomas More Society, we believe every life deserves a defense and we will fight with every legal avenue possible to continue that mission.”

The post Paul Vaughn Wins Settlement After Biden Admin Targeted Him and His Family appeared first on LifeNews.com.

The research, published in the journal Scientific Reports in 2020, used full-thickness skin from the scalps of babies aborted at 18 to 20 weeks of pregnancy—roughly five months gestation—to create “humanized” mice and rats for studying the human immune system. Photographs accompanying the study show the grafted tissue growing tufts of fine baby hair on the animals.

Federal records confirm that Fauci’s NIAID provided approximately $430,000 in grants to the University of Pittsburgh researchers in 2018 and 2019 for the project. Additional NIH support was also listed.

Click here to sign up for pro-life news alerts from LifeNews.com

Pro-life leaders stress that, as the longtime head of NIAID, Fauci owned ultimate oversight of how those grants were spent.

“Dr. Anthony Fauci owns every bit of this study and this issue because as the head of the NIAID office, the buck stops with him in terms of how those grants are spent,” said David Daleiden of the Center for Medical Progress.

Daleiden noted that Fauci told Congress the work proceeded “with the appropriate oversight and guidelines,” yet later copied a media headline into his personal notes disputing any personal role.

Daleiden and other pro-life advocates have highlighted the disturbing implications of the procedure itself. Obtaining intact scalps from five-month-old aborted babies indicates the children’s heads were likely whole, raising the possibility the tissue came from partial-birth abortions or infants delivered alive.

“You can actually see the photographs in the published study of little baby scalps grafted onto the backs of lab rats growing little baby hairs,” Daleiden said. “Those would have been the little hairs growing on heads of little infants … if they hadn’t been killed by abortion and then stitched onto lab rats for experimentation.”

The University of Pittsburgh has long drawn scrutiny from the pro-life movement as a major center for the collection and use of aborted fetal body parts. In 2021, the Center for Medical Progress released grant records and video evidence suggesting the university altered abortion methods to maximize usable tissue for its “Tissue Hub,” a practice critics say violates federal law.

Congressional concern prompted an official request for investigation. Then-HHS Inspector General Christi Grimm indicated her office would follow up. Yet newly released Freedom of Information Act documents obtained by Judicial Watch and independent researchers show that any probe remains incomplete or unresolved more than four years later.

Heavily redacted records reveal a cozy relationship between NIH officials and Pitt administrators, including a hastily arranged Zoom call after the university complained of being “unfairly targeted.” No public announcement has confirmed whether the investigation concluded or what findings, if any, resulted.Pro-life groups continue to demand a full, transparent investigation.

“As a taxpayer, I was horrified to learn that our government is actively funding this cruelty,” said Herb Geraghty, executive director of Rehumanize International and a University of Pittsburgh graduate.

Advocates have called on the incoming NIH director to audit past failures, publicly release the results of any HHS probe, and end all federal support for research using organs and tissue from aborted children.

From the pro-life perspective, the experiments represent a profound moral failure: the deliberate destruction of unborn human lives followed by the industrial use of their body parts in taxpayer-funded laboratories. Critics argue that no scientific goal justifies treating the remains of aborted babies as raw material for animal grafts, and that Fauci’s NIAID enabled the practice without adequate ethical scrutiny.

The post Fauci Directly Funded University Experiments Attaching Aborted Baby Scalps to Rats appeared first on LifeNews.com.